AWA
ADMA icon

Arkadios Wealth Advisors’s ADMA Biologics ADMA Stock Holding History

Arkadios Wealth Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$112K – 932
2024
Q2 		$112K Sell
10,000
-1,260
-11% -$10.6K 0.01% 795
2024
Q1 		$74.3K Hold
11,260
– – 0.01% 681
2023
Q4 		$50.9K Hold
11,260
– – ﹤0.01% 686
2023
Q3 		$40.3K Buy
+11,260
New +$43.3K ﹤0.01% 661

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Arkadios Wealth Advisors's ADMA Position: Q3 2024 in Review

Arkadios Wealth Advisors sold out of ADMA Biologics (ADMA) in Q3 2024, closing a stake of 10,000 shares — an estimated $112K sold.

Arkadios Wealth Advisors first reported a position in ADMA in Q3 2023 and held it in 4 quarters. The position peaked at $112K in Q2 2024. 306 funds tracked by Wall St. Rank hold ADMA as of Q3 2024.

  • Arkadios Wealth Advisors reported no remaining ADMA Biologics position as of Q3 2024 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 10,000 ADMA Biologics shares in Q3 2024, an estimated $112K.
  • Arkadios Wealth Advisors first reported a position in ADMA Biologics in Q3 2023 and held it in 4 quarters.
  • Arkadios Wealth Advisors's ADMA Biologics position peaked at $112K in Q2 2024.
  • 306 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2024.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.